Time-saving multiplex detection of single nucleotide polymorphisms by ultrasensitive DNA microarray

被引:3
作者
Ichikawa, Makiko [1 ]
Miwa, Keishi [1 ]
Yamasaki, Tomo [1 ]
Nakagawa, Izumi [1 ]
Takizawa, Satoko [1 ]
Masuda, Satohiro [2 ]
Inui, Ken-ichi [2 ]
机构
[1] Toray Industries Ltd, New Frontiers Res Labs, Kanagawa 2480036, Japan
[2] Kyoto Univ Hosp, Dept Pharm, Sakyo Ku, Kyoto 6068507, Japan
关键词
diagnostic tool; microarray; multiplex; SNP; transplantation; LIVER-TRANSPLANT PATIENTS; TACROLIMUS; LANSOPRAZOLE; PHARMACOKINETICS; CYP2C19; RABEPRAZOLE; METABOLISM; CYP3A5;
D O I
10.1093/jb/mvq087
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rapid and multiplex detection system using an ultrasensitive DNA microarray was developed and utilized for the analysis of six pharmacokinetically relevant single nucleotide polymorphisms (SNPs) (MDR1-C1236T, MDR1-G2677TA, MDR1-C3435T, CYP3A5-A6986G, CYP2C19-G681A, CYP2C19-G636A) from blood samples derived from liver transplant patients. The SNP detection system is comprised of three processes: multiplex PCR, single base extension with fluorescently labelled di-deoxy-nucleotides and detection by DNA microarray. The entire workflow of this system completes within 5 h. The final genotype call was obtained statistically by Mahalanobis distance which was calculated from the bi-coloured fluorescent signals detected by the microarray. In order to detect the six SNPs, this system required only 50 copies of genomic DNA, and the obtained detection calls completely matched with the results by the sequencing-based genotyping method. With the high sensitivity and rapid processing, our SNP detection system utilizing ultrasensitive microarray is a promising device applicable for diagnostic utility.
引用
收藏
页码:557 / 563
页数:7
相关论文
共 15 条
[1]  
Bell P.A., 2002, Biotechniques, pS70
[2]   Multiplexed genotyping with sequence-tagged molecular inversion probes [J].
Hardenbol, P ;
Banér, J ;
Jain, M ;
Nilsson, M ;
Namsaraev, EA ;
Karlin-Neumann, GA ;
Fakhrai-Rad, H ;
Ronaghi, M ;
Willis, TD ;
Landegren, U ;
Davis, RW .
NATURE BIOTECHNOLOGY, 2003, 21 (06) :673-678
[3]   Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5 [J].
Hosohata, Keiko ;
Masuda, Satohiro ;
Ogura, Yasuhiro ;
Oike, Fumitaka ;
Takada, Yasutsugu ;
Katsura, Toshiya ;
Uemoto, Shinji ;
Inui, Ken-ichi .
DRUG METABOLISM AND PHARMACOKINETICS, 2008, 23 (02) :134-138
[4]   Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations [J].
Itagaki, F ;
Homma, M ;
Yuzawa, K ;
Nishimura, M ;
Naito, S ;
Ueda, N ;
Ohkohchi, N ;
Kohda, Y .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (08) :1055-1059
[5]   PHARMACOKINETICS OF TACROLIMUS IN LIVER-TRANSPLANT PATIENTS [J].
JUSKO, WJ ;
PIEKOSZEWSKI, W ;
KLINTMALM, GB ;
SHAEFER, MS ;
HEBERT, MF ;
PIERGIES, AA ;
LEE, CC ;
SCHECHTER, P ;
MEKKI, QA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (03) :281-290
[6]   Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients [J].
Masuda, S ;
Goto, M ;
Fukatsu, S ;
Uesugi, M ;
Ogura, Y ;
Oike, F ;
Kiuchi, T ;
Takada, Y ;
Tanaka, K ;
Inui, KI .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (01) :90-102
[7]   Ultrasensitive DNA chip: Gene expression profile analysis without RNA amplification [J].
Nagino, Kunihisa ;
Nomura, Osamu ;
Takii, Yuki ;
Myomoto, Akira ;
Ichikawa, Makiko ;
Nakamura, Fumio ;
Higasa, Masashi ;
Akiyama, Hideo ;
Nobumasa, Hitoshi ;
Shiojima, Satoshi ;
Tsujimoto, Gozoh .
JOURNAL OF BIOCHEMISTRY, 2006, 139 (04) :697-703
[8]  
Pearce RE, 1996, J PHARMACOL EXP THER, V277, P805
[9]   A genotype calling algorithm for affymetrix SNP arrays [J].
Rabbee, N ;
Speed, TP .
BIOINFORMATICS, 2006, 22 (01) :7-12
[10]   Tacrolimus - A further update of its use in the management of organ transplantation [J].
Scott, LJ ;
McKeage, K ;
Keam, SJ ;
Plosker, GL .
DRUGS, 2003, 63 (12) :1247-1297